Close Menu

OB/GYN

CEO Peter Meldrum said at a conference this week that Myriad's sales force "provides doctors [with] the tools to do counseling" in-house, and as a result, physicians can bill insurers directly for the service.

More OB/GYN sales reps, expanded direct-to-consumer marketing campaigns, and more company-hired physicians reaching out to other doctors are a few “initiatives [that] will be beneficial to the company in combating this weak economy,” Myriad CEO Peter Meldrum said during an earnings call this week.

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.